About: Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scholarly article by Hideyasu Yamada et al published 2018 in International Journal of Chronic Obstructive Pulmonary Disease

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у 2018 (uk) article scientifique publié en 2018 (fr) im Jahr 2018 veröffentlichter wissenschaftlicher Artikel (de) scholarly article by Hideyasu Yamada et al published 2018 in International Journal of Chronic Obstructive Pulmonary Disease (en)
publication date	wds:Q57817674-6ECF3DF6-9062-4A51-A03D-4E82D9A2D845
publication date	2018-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57817674-B424B224-B573-4461-90B8-36C8D1E13ED9
language of work or name	English
cites work	wds:Q57817674-009D923C-2171-4C5A-9973-51DCB5BB683F wds:Q57817674-054C7943-6D77-4F76-B67A-754E3FAB78EA wds:Q57817674-1B7B3CB7-5ADA-4A34-B077-88700260D0FC wds:Q57817674-3EECF46B-9051-4D55-9A8A-90E230AA486E wds:Q57817674-4EC1D44A-77DE-48D8-A033-5086CEA551E8 wds:Q57817674-6B49F41D-3B4A-4722-9493-EB8D0BB64D32 wds:Q57817674-6FAB2EFA-7A48-4C76-9FB3-4B1B96452CF9 wds:Q57817674-B4BD475B-772F-4C0E-B4AC-A3751A926860 wds:Q57817674-B7409DD6-ACAB-4AA4-A4E2-540D1E6306B2 wds:Q57817674-C090B25E-4810-42A5-8845-91FA8C9F7E0C wds:Q57817674-C3608088-76F2-4F81-9281-F8E07166913D wds:Q57817674-C46131C7-3590-455E-AA42-01C84B09B7BD wds:Q57817674-E742DBE6-7F9F-41A4-8A78-780AF75349B0 wds:Q57817674-E91C2D56-78E1-4F92-80BE-025ED55A34AC wds:Q57817674-F1C13810-C4C9-4653-9706-0296A91B8529 wds:Q57817674-FEE41744-8030-48E1-82BC-2898D5A208EE
cites work	Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). [Guideline of respiratory function tests--spirometry, flow-volume curve, diffusion capacity of the lung] COPD in Japan: the Nippon COPD Epidemiology study Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Development and first validation of the COPD Assessment Test. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Properties of the COPD assessment test in a cross-sectional European study. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi. Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Genetic Control of Fatty Acid β-Oxidation in Chronic Obstructive Pulmonary Disease Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis.
author name string	wds:Q57817674-0785795D-93D2-48ED-96E3-63F19E8A4F16 wds:Q57817674-5041AEB9-F629-431C-B319-42850A4BE539 wds:Q57817674-5D9DDBEB-E811-423E-B149-991487FE3708
author name string	Nobuyuki Hizawa Hideyasu Yamada Norihito Hida
rdfs:label	Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (en) Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (nl)
skos:prefLabel	Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (en) Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (nl)
name	Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (en) Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (nl)
title	wds:Q57817674-E3FF4F8A-9980-4042-BB75-395A4F93AEB4
title	Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan (en)
page(s)	wds:Q57817674-C7ED2A1B-DD43-434B-BA2B-CE7879813825
page(s)	3141-3147
instance of	wds:Q57817674-A0DFAAA8-A9A1-48AB-B030-5178AAFC2E06
instance of	scholarly article
main subject	wds:Q57817674-37885CC9-BBA0-466B-8459-F3F96297A651 wds:Q57817674-ECCDC7CC-BE89-4C49-9A37-202F947F6C61
main subject	chronic obstructive pulmonary disease health policy
PubMed ID	wds:Q57817674-4FEABF4B-66AB-44DD-9024-28D24F212AF5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30349222
PubMed ID	30349222
published in	wds:Q57817674-F44B14F8-CC06-407B-B670-8EE5092808A6
published in	International Journal of Chronic Obstructive Pulmonary Disease
volume	wds:Q57817674-8D688218-14C1-42FF-A4F1-C1C31F0345CD
volume	13
DOI	wds:Q57817674-86883B31-8D7C-4A40-A4AE-A2EA946C688D
DOI	http://dx.doi.org/10.2147/COPD.S179285
DOI	10.2147/COPD.S179285
copyright license	wds:Q57817674-8f8bba1b-9d5f-4617-8460-a4bbcd3150ab
copyright status	wds:Q57817674-7e2c567c-a26b-49b0-ad6a-26d269547689
copyright license	Creative Commons Attribution-NonCommercial 3.0 Unported
copyright status	copyrighted
PMCID	wds:Q57817674-33037A9F-E5E5-4758-9BE6-FA3FF76193B8
PMCID	6183692
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57817674

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software